Nynomic AG Sees Positive Q1 Results, Upgrades Outlook

Nynomic AG reported an 8% year-over-year sales increase in Q1, reaching €22.3 million, marking a return to top-line growth since Q1 2024. The company's EBIT transitioned to positive, at €0.1 million compared to a €0.9 million loss the previous year. This improvement follows the NyFIT2025 efficiency program, which is delivering on promised structural margin recovery. Approximately €5 million in annual savings now support this progress.

The order backlog saw a significant rise of 23% year-over-year, totaling €55.6 million, with an order intake at €32.9 million, a notable 80% growth from last year. Semiconductor gas analysis solutions are key drivers of this performance. Nynomic confirms its full-year sales guidance of €100-105 million for 2026.

The company's EBIT margin estimate remains between 6-8% for FY26, supported by NyFIT savings and revenue scaling. Subsidiary LayTec advances with significant demand for semiconductor manufacturing solutions, predicting a continued rise in compound semiconductor needs.